Skip to main content
. 2013 Nov;29(11):1455–1464. doi: 10.1089/aid.2013.0043

FIG. 4.

FIG. 4.

The binding of HP-HSA to soluble CD4 (sCD4) and gp120, as assessed by enzyme-linked immunosorbent assay (ELISA). (A) Dose-dependent binding of HP-HSA to sCD4; (B) dose-dependent binding of HP-HSA to gp120 from HIV-1IIIB; (C) dose-dependent binding of HP-HSA to gp120 from HIV-1BaL. Data are presented as means±SD.

HHS Vulnerability Disclosure